Colorectal Liver Metastases Clinical Trial
Official title:
Colorectal Metastatic Liver Disease: Efficacy of Irreversible Electroporation (IRE) - a Phase II Clinical Trial (COLDFIRE-2 Study)
Irreversible electroporation (IRE) is a new, minimal-invasive image-guided treatment method for tumors not amenable for surgical resection or thermal ablation, due to vicinity near vital structures such as vessels and bile ducts. With IRE, multiple electrical pulses are applied to tumorous tissue. These pulses alter the existing transmembrane potential of the cell membranes, and create 'nanopores', after which the cell dies through loss of homeastasis. The purpose of this study is to investigate the efficacy of percutaneous and open IRE in the treatment of patients with colorectal liver metastases (CRLM) that are unsuitable for resection or thermal ablation due to vicinity to vulnerable structures such as vessels and bile ducts. Other objectives are safety, feasibility (technical success) and imaging characteristics on follow-up (PET-)CT and PET-MRI and the value of these imaging modalities in dianosing local site recurrence (LSR) or residual disease (RD). 29 patients with histologically confirmed colorectal carcinoma who present with unresectable and not thermally ablative CRLM< 3.5cm suitable for IRE will undergo percutaneous or open irreversible electroporation of the tumor using CT and ultrasound guidance. All (serious) adverse events are registered. One day post-IRE MRI is performed to assess technical success. Follow-up will consist of frequent (PET-)CT and (PET-)MRI scanning to localize residual or recurrent disease. Overall technique effectiveness is determined 1 year after treatment. The investigators hypothesize that IRE for central CRLM will lead to good tumor control without causing severe complications.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01255007 -
Comparison of Primovist-enhanced MRI, Diffusion Weighted MRI and Multidetector CT of Colorectal Liver Metastases
|
N/A | |
Completed |
NCT00779272 -
Impact of Preoperative Chemotherapy on Complications and Regeneration After Resection of Colorectal Liver Metastases
|
N/A | |
Active, not recruiting |
NCT00797251 -
Anatomical Right Posterior Sectionectomy of the Liver by IOUS-Guided Finger Compression
|
N/A | |
Recruiting |
NCT06045286 -
High- and Low-dose Radiotherapy Combined With PD-1 Inhibitors for MSS CRLM
|
Phase 1 | |
Recruiting |
NCT04870879 -
Colorectal Metastasis and Liver Transplantation With Organs From Deceased Donors
|
N/A | |
Completed |
NCT01799044 -
Pilot-study: Non-thermal Ablation Using Irreversible Electroporation to Treat Colorectal Liver Metastases
|
Phase 1 | |
Terminated |
NCT00508872 -
Folfox-B Study for Patients With Colorectal Liver Metastases
|
Phase 2 | |
Recruiting |
NCT05877001 -
The Safety and Efficacy of HAIC+Tislelizumab+Regorafenib in Patients With Colorectal Liver Metastases
|
Phase 2 | |
Completed |
NCT00942292 -
The Effect of Fish Oils on Human Hepatic Colorectal Metastases
|
Phase 2 | |
Recruiting |
NCT01191632 -
Effect of Neoadjuvant Radiation on Tumor Infiltrating T-cells by Low Dose Radiation in Colorectal Liver Metastases
|
Phase 1/Phase 2 | |
Completed |
NCT00119899 -
Utility of FDG-PET Scan on the Selection of Patients for Resection of Hepatic Colorectal Metastases
|
Phase 3 | |
Completed |
NCT00184834 -
Quality of Life and Liver Metastases
|
N/A | |
Completed |
NCT00557557 -
Safety Study of Oxaliplatin and 5-fluorouracil Followed by FUDR for Unresectable Colorectal Liver Metastases
|
Phase 1 | |
Recruiting |
NCT05468593 -
Patient Outcomes After Hepatic Artery Infusion Pump Placement
|
||
Completed |
NCT02615665 -
Intratumoral CD3+ and NKp46+ Cells in Colorectal Liver Metastases
|
N/A | |
Terminated |
NCT01318447 -
CyberKnife® for Hepatic Metastases From Colorectal Cancer
|
Phase 2 | |
Completed |
NCT00885950 -
Prevention of the Hepatic Sinusoidal Obstruction Syndrome by Means of Anticoagulants
|
N/A | |
Completed |
NCT02331641 -
Multiple Minor Hepatectomies Versus Major or Extended Hepatectomies for Colorectal Liver Metastases.
|
N/A | |
Completed |
NCT00600522 -
Alternative Surgical Policy for Central Liver Tumors
|
N/A | |
Recruiting |
NCT05265169 -
Ablation With Confirmation of Colorectal Liver Metastases (ACCLAIM)
|
N/A |